Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.304, 2001-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
UK NICE issues guidance on pioglitazone for type 2 diabetes
Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. :
UK NICE issues rosiglitazone guidance for type 2 diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :
UK NICE issues rosiglitazone guidance for type 2 diabetes
Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. :
UK NICE issues COX-2 inhibitor guidance for OA, RA
Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. :
UK NICE issues COX-2 inhibitor guidance for OA, RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 324, 2001-01 ,pp. :